“…1 H NMR (400 MHz, CDCl 3 ) δ 5.29-5.19 (m, 1H, H-22), 5.08 (dd, J = 15.1, 9.2 Hz, 0.46H, H-23), 4.95 (dd, J = 15.1, 9.4 Hz, 0.61H, H-23), 4.17-4.03 (m, 2H, H-1 ′ ), 3.32 (d, J = 0.7 Hz, 3H, OCH 3 ), 2.77 (t, J = 2.4 Hz, 1H, H-6), 2.40-2.28 (m, 1H, H-2 ′ ), 2.14-1.57 (m, 8H), 1.53-0.96 (m, 24H), 0.90-0.79 (m, 6H, H-1, H-3, H-9 and H-29), 0.72 (d, J = 2.6 Hz, 3H, H-18), 0.65 (t, J = 4.4 Hz, 1H, H-4), 0.43 (dd, J = 8.0, 5.0 Hz, 1H, H-4). 13 Ethyl (24R,25RS)-6β-Methoxy-3α,5-cyclo-5α-stigmastan-26-oate (12) This compound was synthesized from ∆22 analogue 11 (0.45 g, 0.93 mmol) via catalytic hydrogenation using Pd on a charcoal catalyst, according to a procedure from the literature [26] as follows: yield: 0.40 g, 0.82 mmol, 88%. 1 (24R,25RS)-6β-Methoxy-3α,5-cyclo-5α-stigmastan-26-ol (13) To a stirred suspension of LiAlH 4 (0.30 g, 8.0 mmol) in dry THF (30 mL) under nitrogen atmosphere, a solution of ethyl ester 12 (0.39 g, 0.80 mmol) in dry THF (20 mL) was added, and the mixture was stirred over night at room temperature.…”